Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

Name: Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial
Published: 2006
License: Public Domain

Acorda Therapeutics · 2006

ClinicalTrials.gov · Datasets · License: Public Domain · 2006

Open Source ↗

ms multiple-sclerosis walking

multiple sclerosis, ms, walking, leg strength, demyelination, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

Related documents